Immucell Corporation (ICCC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immucell Corporation  (NASDAQ: ICCC)


Immucell's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immucell's ROI in the second quarter of 2026?
Immucell Corporation achieved a return on average invested assets (ROI) of 1.95 % in its second quarter of 2026, this is above ICCC's average return on investment of -1.71%.
Immucell Corporation invested over the 12 months ending in its second quarter of 2026 $40 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 106 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2273 to 2634.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -2.1 % 1.9 % 4.77 % 9.74 % 7.71 %
Y / Y Net Income Change TTM -55.31 % - - - -
Investment (TTM) in Millions 41 40 39 42 42
Return On Investment (TTM) 1.95 % -1.34 % -2.53 % 5.58 % 4.28 %
ICCC's Overall Ranking # 2634 # 2273 # 2465 # 1099 # 1255
Seq. Investment Change TTM -0.93 % -0.95 % -1.28 % 1.06 % 3.12 %
Seq. Net Income Change TTM - - - 31.9 % -
Net Income (TTM) in Millions 1 -1 -1 2 2

ICCC Company Profile >> Back to ICCC Roi Comparisons >> See Annual ICCC Return On Investment



Return On Investment ICCC's Ranking
Within: No.
Industry # 1
Sector # 107
Overall # 2634

Return On Investment Statistics
High Average Low
10.01 %
-1.71 %
-15.55 %
(Dec 31 2015)   (Sep 30 2023)







Financial Statements
Immucell's II. Quarter Investments $ 41 Millions ICCC's Balance sheet
Immucell's II. Quarter Income $ 2 Millions Quarterly ICCC's Income Statement
ICCC's Income by Division See ICCC's Income by Division


ICCC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 39 41 36 42 42
Y / Y Investment Growth -5.25 % 14.51 % -14.97 % -0.34 % 9.94 %
Net Income in Millions -1 -2 -6 -2 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -2.7 % -5.3 % -16.25 % -5.97 % -0.19 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ICCC's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ICCC's Competitors
Subscribers only: Roi for Immucell's Suppliers
Subscribers only: Return On Investment for ICCC's Customers

Other Ratios
ICCC's Roa ICCC's Inventory Turnover Ratio ICCC's Growth Rates ICCC's Dividend Statistics
ICCC's Profitability Ratios ICCC's Asset Turnover Ratio ICCC's Dividend Growth
ICCC's Roe ICCC's Valuation Ratios ICCC's Financial Strength Ratios ICCC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %

Date modified: 2026-09-26T06:50:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.